thirteen
monoclon
antibodi
mab
glycoprotein
g
vesicular
stomat
viru
vsv
serotyp
indiana
prepar
examin
effect
variou
biolog
activ
vsv
includ
vitro
infect
hemagglutin
adsorpt
cell
mediat
cell
fusion
competit
bind
assay
mab
reveal
presenc
least
seven
distinct
antigen
determin
epitop
g
protein
case
overlap
among
epitop
variou
degre
observ
partial
inhibit
bind
enhanc
mab
epitop
one
epitop
react
denatur
g
protein
western
immunoblot
analysi
four
epitop
epitop
involv
neutral
two
epitop
hemagglutin
inhibit
none
mab
inhibit
adsorpt
radiolabel
vsv
cell
mab
epitop
slightli
enhanc
viru
adsorpt
neutral
epitop
except
epitop
epitop
associ
inhibit
vsvmediat
cell
fusion
result
show
direct
spatial
relationship
epitop
recogn
mab
function
site
g
protein
insight
structur
function
g
protein
mani
envelop
virus
includ
vesicular
stomat
viru
vsv
famili
rhabdovirida
genu
vesiculoviru
transfer
nucleocapsid
cytoplasm
host
cell
adsorpt
receptormedi
endocytosi
follow
fusion
endosom
membran
glycoprotein
g
vsv
sole
protein
anchor
viral
envelop
play
critic
role
earli
stage
viru
infect
mani
biolog
properti
g
protein
associ
viru
entri
includ
adsorpt
host
cell
hemagglutin
ha
mediat
vitro
cellcel
fusion
cellcel
fusion
occur
low
ph
mimic
acid
environ
endosom
lumen
expect
central
role
infect
g
protein
also
give
rise
react
neutral
antibodi
recent
year
much
effort
made
reveal
structurefunct
relationship
g
protein
especi
regard
role
fusion
underli
molecular
mechan
still
poorli
understood
one
approach
structurefunct
relationship
surfac
glycoprotein
virus
analyz
site
effect
monoclon
antibodi
mab
bind
product
mab
g
protein
two
major
serotyp
vsv
indiana
new
jersey
report
two
research
group
mab
mainli
use
map
neutral
nonneutr
epitop
g
protein
analyz
mutat
lead
antigen
variat
g
protein
effect
mab
specif
react
g
protein
biolog
function
neutral
report
present
studi
prepar
thirteen
mab
specif
seven
distinct
epitop
g
protein
vsvindiana
examin
effect
variou
biolog
activ
vsv
includ
vitro
infect
ha
adsorpt
cell
mediat
cellcel
fusion
find
defin
spatial
relationship
epitop
recogn
mab
function
g
protein
san
juan
strain
vsvindiana
origin
provid
dr
r
r
wagner
univers
virginia
obtain
dr
k
yamamoto
nation
institut
health
tokyo
viru
stock
prepar
infect
cell
japanes
cancer
research
resourc
bank
multipl
pfucel
viru
harvest
h
postinfect
concentr
ultrafiltr
ultracentrifug
purifi
sucros
densiti
gradient
centrifug
prepar
contain
mgml
viral
protein
x
store
protein
content
prepar
determin
bca
protein
assay
reagent
pierc
chemic
co
rockford
il
usa
bovin
serum
albumin
bsa
standard
viru
infect
determin
plaqu
monolay
cultur
cell
g
protein
extract
purifi
viru
mm
sigma
chemic
co
st
loui
mo
usa
describ
petri
wagner
remov
nucleocapsid
ultracentrifug
x
g
supernat
contain
g
protein
dialyz
mm
hepe
ph
contain
naci
g
protein
thu
obtain
free
viru
protein
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
stain
coomassi
brilliant
blue
immun
femal
balbc
mice
subcutan
inject
twice
gg
purifi
g
protein
emulsifi
quantiti
freund
complet
freund
incomplet
adjuv
respect
addit
two
intraperiton
inject
gg
g
protein
given
three
day
fusion
hybridoma
product
final
gg
g
protein
inject
intraven
spleen
cell
immun
mice
sp
balbc
mous
nonsecretori
plasmacytoma
cell
fuse
polyethylen
glycol
accord
oi
herzenberg
novel
vsvmediat
cell
fusion
method
describ
previous
media
prepar
hat
select
hybridoma
describ
previous
week
hybridoma
screen
product
antig
protein
antibodi
enzymelink
immunosorb
assay
elisa
purifi
g
protein
antigen
see
posit
cultur
clone
sever
time
limit
dilut
method
isotyp
specif
antibodi
determin
mous
monoclon
antibodi
isotyp
kit
amersham
intern
buckinghamshir
england
thirteen
hybridoma
establish
overgrown
serumfre
medium
iscov
modifi
dulbecco
medium
sigma
contain
mgml
bsa
mm
sodium
pyruv
gibco
grand
island
ny
usa
tgml
bovin
insulin
sigma
ggml
ironsatur
human
transferrin
mile
scientif
napervil
il
usa
tm
gm
ethanolamin
tgmt
linol
acid
tg
ml
oleic
acid
ggml
palmit
acid
ggml
gentamicin
mab
cultur
supernat
precipit
ammonium
sulfat
satur
precipit
purifi
high
perform
liquid
chromatographi
hydroxyapatit
bead
affin
chromatographi
protein
gsepharos
pharmacia
uppsala
sweden
eluat
concentr
ml
membran
ultrafiltr
tool
wt
cutoff
centriprep
amicon
danver
usa
dialyz
phosphatebuff
salin
pb
antibodi
concentr
determin
absorb
nm
extinct
coeffici
per
mg
protein
use
neg
control
variou
assay
two
mab
prepar
nation
institut
health
purifi
procedur
one
ig
specif
core
antigen
felin
immunodefici
viru
unpubl
ig
specif
sheep
red
blood
cell
crossreact
goos
erythrocyt
product
antig
protein
antibodi
hybridoma
cultur
supernat
examin
elisa
well
microtit
plate
costar
costar
cambridg
usa
coat
purifi
g
protein
ggml
sodium
carbon
buffer
room
temperatur
well
wash
pb
contain
vv
tween
pbstween
block
overnight
wv
gelatin
pb
wash
cultur
supernat
ad
well
plate
incub
h
room
temperatur
antibodi
bound
detect
incub
h
room
temperatur
alkalin
phosphataseconjug
goat
antimous
igg
tago
tago
inc
burlingam
ca
usa
dilut
pbstween
enzym
reaction
start
ad
mgml
pnitrophenylphosph
wako
pure
cemic
ind
osaka
japan
vv
diethanolamin
ph
contain
mm
nagata
et
al
absorb
nm
measur
eia
autoread
sanko
junyaku
co
tokyo
japan
posit
control
dilut
mous
immun
serum
use
control
usual
show
absorb
approxim
incub
rain
room
temperatur
well
absorb
higher
regard
posit
purifi
mab
titrat
elisa
compar
rel
reactiv
well
plate
coat
vsv
virion
ggml
instead
g
protein
rel
reactiv
defin
concentr
mab
need
attain
absorb
valu
posit
control
purifi
vsv
separ
sdspage
polyacrylamid
gel
reduc
condit
protein
separ
blot
onto
immobilon
membran
millipor
corp
bedford
usa
accord
towbin
et
al
blot
allow
react
cultur
supernat
establish
hybridoma
specif
band
visual
alkalin
phosphataseconjug
goat
antimous
igg
tago
bcip
nbt
phosphatas
substrat
system
kirkegaard
perri
lab
inc
gaithersburg
md
usa
portion
purifi
mab
mix
biotinyt
nhydroxysuccinimid
ester
nhslcbiotin
pierc
ml
sodium
bicarbon
ph
incub
h
room
temperatur
mixtur
dialyz
extens
pb
bsa
ad
final
concentr
mgml
competit
bind
assay
well
plate
coat
purifi
vsv
tg
ml
block
wv
unfat
bovin
milk
pb
serial
dilut
unlabel
competitor
mab
x
x
mgml
ad
well
tl
well
plate
incub
h
room
temperatur
subsequ
gl
biotinyl
mab
mix
competitor
mab
concentr
biotinyl
mab
ggml
ggml
ggml
mab
concentr
halfmaxim
titrat
curv
within
rang
bind
linear
incub
overnight
biotinyl
mab
bound
detect
dilut
alkalin
phosphataseconjug
streptavidin
bethesda
research
lab
gaithersburg
md
usa
dilut
made
pbstween
contain
wv
unfat
bovin
milk
enzym
reaction
absorb
determin
carri
describ
assay
perform
duplic
result
express
percentag
bind
calcul
formula
averag
ofabsorb
presenc
competitor
bind
x
averag
ofabsorb
absenc
competitor
neutral
assay
stock
vsv
dilut
final
concentr
approxim
pfuml
bicarbonatefre
eagl
minimum
essenti
medium
mem
nissui
pharmachem
co
tokyo
japan
contain
mgml
bsa
mm
hepe
ph
viru
mix
equal
volum
serial
twofold
dilut
purifi
mab
ggml
medium
mixtur
incub
h
plate
duplic
monolay
cell
cultur
plate
plaqu
assay
glwell
neutral
antibodi
titer
defin
reciproc
highest
dilut
reduc
plaqu
control
without
mab
hemagglutin
inhibit
hi
assay
hemagglutin
unit
vsv
vbottom
microtit
plate
describ
halonen
et
al
except
goos
erythrocyt
use
treatment
trypsin
sigma
lgml
rain
pretreat
erythrocyt
enhanc
ha
thu
increas
sensit
hi
unpubt
data
reciproc
highest
dilut
purifi
mab
caus
complet
inhibit
hemagglutin
taken
hi
titer
adsorpt
assay
vsv
prepar
addit
ciml
l
amersham
infect
medium
describ
bailey
et
al
radiolabel
virion
concentr
purifi
describ
unlabel
viru
final
prepar
free
contamin
label
materi
judg
sdspage
autoradiographi
final
prepar
contain
x
pfuml
mgml
viral
protein
specif
activ
x
cpmtg
radiolabel
viru
absorb
cell
quantifi
essenti
describ
matlin
etal
cell
grown
confluenc
cultur
plate
cellswel
wash
twice
bind
medium
bicarbonatefre
mem
buffer
mm
hepe
ph
contain
mgml
bsa
cool
rain
ice
radiolabel
purifi
viru
mix
purifi
mab
variou
concentr
bind
medium
mixtur
incub
h
chill
plate
duplic
cell
glwell
incub
h
ice
unbound
viru
remov
cell
wash
four
time
bind
medium
cell
bound
viru
solubil
ml
solub
nen
research
product
boston
usa
radioact
measur
liquid
scintil
counter
averag
radioact
bound
cell
presenc
mab
express
percentag
radioact
bound
absenc
mab
nonspecif
interact
viru
ceil
surfac
plate
minim
ad
bsa
bind
medium
addit
bsa
reduc
nonspecif
bind
label
vsv
surfac
plate
less
input
radioact
amount
viru
use
within
rang
radioact
bound
cell
increas
proport
amount
input
viru
effect
mab
vsvmediat
cell
fusion
assay
inhibit
polykaryon
format
cell
cell
cultur
plate
x
celtswel
h
wash
twice
icecold
bind
medium
bicarbonatefre
mem
buffer
mm
hepe
ph
contain
mgml
bsa
purifi
viru
gg
gl
cold
bind
medium
appli
onto
cell
incub
h
ice
allow
viral
adsorpt
free
viru
remov
cell
treat
ice
min
gml
mab
bind
medium
remov
mab
solut
ml
prewarm
acid
medium
bicarbonatefre
mem
buffer
mm
me
ph
ad
trigger
fusion
plate
incub
min
medium
replac
ml
prewarm
bind
medium
cell
incub
addit
hour
fixat
formalin
pb
stain
hematoxylin
inhibit
polykaryon
formarion
examin
phasecontrast
microscopi
amount
viru
use
assay
enough
induc
fusion
cell
two
fusion
experi
yield
stabl
hybridoma
secret
b
specif
react
g
protein
vsv
characterist
list
tabl
rel
reactiv
vari
rang
still
within
rel
high
rang
c
p
r
e
b
differ
antigen
determin
us
b
except
react
g
protein
western
blot
analysi
competit
bind
e
l
carri
n
g
b
classifi
epitop
g
protein
recogn
typic
result
f
competit
bind
assay
shown
fig
bind
f
biotinyl
b
g
protein
challeng
sever
unlabel
mab
observ
four
type
competit
addit
homolog
b
complet
inhibit
bind
partial
inhibit
bind
mab
light
chain
b
rel
reactiv
defin
elisa
mab
concentr
need
attain
absorb
posit
control
immun
mous
serum
dilut
absorb
valu
c
reactiv
g
protein
western
blot
analysi
epitop
antigen
determin
identifi
competit
bind
assay
among
mab
describ
tabl
tabl
mab
assign
seven
distinct
epitop
g
protein
base
complet
inhibit
unlabel
mab
inhibit
bind
biotinyl
mab
least
excess
biotinyl
mab
less
inhibit
observ
pairwis
assay
mab
consid
share
close
adjac
epitop
seven
epitop
design
ep
ep
mab
epitop
show
similar
pattern
partial
inhibit
enhanc
bind
mab
differ
epitop
tabl
mab
ep
subgroup
two
base
pattern
mab
ep
effect
bind
mab
ep
wherea
mab
ep
enhanc
bind
mab
ep
mab
assay
neutral
activ
plaqu
reduct
test
tabl
mab
assign
four
ep
ep
ep
ep
seven
epitop
neutral
activ
neutral
titer
mab
ep
ep
higher
other
inhibit
hemagglutin
mab
also
examin
tabl
mab
assign
two
epitop
ep
ep
higher
hi
activ
other
goos
erythrocyt
use
experi
pretreat
trypsin
enhanc
sensit
hi
untreat
erythrocyt
gave
similar
result
although
higher
mab
concentr
requir
data
shown
titer
neutral
repres
reciproc
highest
twofold
dilut
purifi
mab
ggml
initi
caus
reduct
plaqu
number
b
titer
hi
repres
reciproc
highest
twofold
dilut
purifi
mab
ggml
initi
inhibit
ha
caus
hau
vsv
control
ig
ig
mab
serumfre
medium
grow
hybridoma
show
hi
activ
examin
mab
influenc
adsorpt
radiolabel
vsv
cell
mab
ep
ep
littl
effect
viru
adsorpt
fig
c
similar
control
mab
fig
h
mab
ep
ep
ep
ep
slightli
reduc
viru
bind
fig
e
f
g
even
highest
concentr
ggml
exert
partial
inhibit
bind
control
hand
mab
slightli
enhanc
vsv
adsorpt
certain
concentr
fig
b
anoth
experi
differ
prepar
radiolabel
vsv
higher
specif
activ
similar
result
obtain
mab
complet
inhibit
viru
bind
mab
ep
enhanc
viru
bind
data
shown
examin
mab
effect
vsvmediat
polykaryon
format
cell
test
whether
mab
inhibit
fusion
induc
vsv
extens
cell
fusion
induc
acid
treatment
virusbound
cell
fig
treatment
unbound
cell
fig
p
mab
react
ep
fig
g
h
ep
fig
ep
fig
complet
inhibit
polykaryocyt
format
mab
fig
af
j
k
neutral
titer
f
respect
reduct
plaqu
shown
third
column
tabl
b
hi
titer
h
u
respect
given
column
tabl
c
inhibit
slight
inhibit
adsorpt
e
enhanc
adsorpt
viru
bind
assay
shown
fig
inhibit
fusion
inhibit
e
test
cell
fusion
activ
w
e
report
first
time
identif
g
protein
epitop
associ
h
fusion
activ
competit
bind
assay
u
u
l
complet
competit
f
pair
b
reveal
presenc
least
seven
distinct
epitop
g
protein
vsvindiana
addit
topograph
relationship
n
g
f
epitop
suggest
partial
inhibit
enhanc
f
bind
f
b
tabl
particular
associ
n
g
ep
ep
e
p
w
u
l
quit
possibl
sinc
u
u
l
bind
enhanc
f
respect
b
observ
enhanc
p
r
b
b
l
due
v
n
g
e
u
alloster
alter
g
protein
bind
first
b
therebi
result
increas
bind
f
second
b
similar
competit
bind
assay
antig
protein
b
report
volk
etal
lefrancoi
lyle
w
h
e
n
r
e
epitop
g
protein
vsvindiana
respect
enhanc
bind
f
u
n
also
lefrancoi
lyle
f
seven
epitop
identifi
g
protein
b
u
one
ep
react
respect
b
even
western
blot
analysi
p
r
e
u
b
l
linear
epitop
depend
secondari
structur
b
assign
four
epitop
ep
ep
ep
ep
vsvneutral
activ
although
vari
effici
previou
report
also
demonstr
number
neutral
epitop
g
protein
vsvindiana
mab
ep
ep
show
hi
activ
proxim
hi
epitop
suggest
competit
bind
assay
like
epitop
concurr
form
function
domain
ha
activ
hi
epitop
alway
neutral
epitop
differ
fusioninhibit
epitop
indic
site
involv
ha
activ
differ
involv
function
gener
viral
ha
equival
viral
attach
cell
howev
hi
mab
inhibit
vsv
bind
cell
littl
correl
two
activ
like
ascrib
differ
target
cell
andor
condit
assay
l
result
anoth
experi
show
hi
mab
markedli
inhibit
bind
radiolabel
vsv
goos
erythrocyt
bind
measur
condit
hi
assay
data
shown
attempt
identifi
cellbind
domain
g
protein
unsuccess
studi
bind
assay
mab
complet
inhibit
vsv
adsorpt
fig
mab
ep
ep
ep
ep
high
concentr
slightli
inhibit
vsv
adsorpt
low
inhibitori
effect
relat
effici
neutral
hi
lack
complet
inhibit
suggest
neutral
mab
prepar
studi
block
viru
infect
step
subsequ
adsorpt
hand
certain
concentr
mab
one
neutral
epitop
rather
enhanc
vsv
adsorpt
although
difficult
explain
biolog
signific
enhanc
effect
similar
enhanc
vsv
adsorpt
immun
serum
report
schlegel
wade
suggest
vsvantibodi
complex
bind
differ
addit
cell
bind
site
thu
alter
adsorpt
effici
explan
may
given
enhanc
effect
mab
ep
fusion
inhibit
assay
mab
react
three
epitop
ep
ep
ep
inhibit
vsvmediat
cell
fusion
epitop
probabl
locat
close
fusogen
domain
g
protein
although
hydrophob
domain
involv
fusion
identifi
sever
viral
fusion
protein
domain
identifi
g
protein
vsv
recent
find
introduct
glycosyl
site
residu
g
protein
result
fusiondefect
mutant
suggest
residu
involv
fusion
activ
fusioninhibit
mab
may
recogn
residu
locat
fusioninhibit
epitop
requir
found
presenc
multipl
epitop
relat
fusion
activ
suggest
differ
region
g
protein
contribut
fusion
activ
partnership
might
explain
lack
highli
hydrophob
fusion
sequenc
g
protein
vsv
fusioninhibit
mab
neutral
activ
vsv
infect
process
endocytosi
b
u
n
virion
fusion
viral
envelop
endosom
e
b
r
n
e
necessari
entri
nucleocapsid
cytoplasm
fusioninhibit
mab
neutral
vsv
probabl
block
fusion
stage
infect
process
analyz
structurefunct
relationship
g
protein
studi
current
aim
locat
epitop
g
protein
test
reactiv
mab
g
protein
fragment
express
escherichia
coli
